πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10723803

CD47 targeted therapies for the treatment of infectious disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10722459

Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and relat

United Kingdom Research and Innovation Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10723787

Methods for alleviating symptoms of sporadic amyotrophic lateral sclerosis by neutralizing

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10722561

Aquaporin 2 protects cattle from ticks and tick-borne parasites

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10723857

Polyimide aerogels with reduced shrinkage from isothermal aging

United States of America as represented by the Administrator of NASA Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10724007

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716809

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716843

Immune enhancing recombinant dengue protein

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716793

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10711068

Anti-CD133 monoclonal antibodies and related compositions and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10709790

Chemical conjugates of Evans Blue derivatives and their use in the production of long-acti

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10702525

Pyrimidine derivatives as anti-diabetic agents

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10702543

Intranuclear protein transduction through a nucleoside salvage pathway

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10703746

Mutant IDH1 inhibitors useful for treating cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10703816

M971 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10704076

Multi-tiered high through-put screen for compounds effective against bacterial biofilm and

Government of the United States, as represented by the Secretary of the Air Force Β· Granted Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10696631

Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging ag

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10695308

Inhalation formulations of treprostinil

United Therapeutics Corporation Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10695355

Methods for pharmacologic treatment of stroke

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10695414

Modulation of replicative fitness by deoptimization of synonymous codons

THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10688063

Treating and/or preventing insulin-resistance related weight gain

The United States Government as Represented by the Department of Veterans Affairs of General Counsel- PSG IV (024) Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10689422

Recombinant polypeptide construct comprising multiple enterotoxigenic Escherichia coli fim

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10689456

Anti-CD70 chimeric antigen receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10683363

Targeting intracellular target-binding determinants with intracellular antibodies

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted